PT Pyridam Farma Tbk Statistics

Total Valuation

PT Pyridam Farma Tbk has a market cap or net worth of IDR 2.48 trillion. The enterprise value is 5.86 trillion.

Market Cap	2.48T
Enterprise Value	5.86T

Important Dates

The next estimated earnings date is Wednesday, March 26, 2025.

Earnings Date	Mar 26, 2025
Ex-Dividend Date	n/a

Share Statistics

PT Pyridam Farma Tbk has 11.81 billion shares outstanding. The number of shares has increased by 1,500.00% in one year.

Current Share Class	n/a
Shares Outstanding	11.81B
Shares Change (YoY)	+1,500.00%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	n/a
Float	4.40B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.34
PB Ratio	2.07
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-23.79
EV / Sales	4.36
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-89.08

Financial Position

The company has a current ratio of 0.74, with a Debt / Equity ratio of 3.24.

Current Ratio	0.74
Quick Ratio	0.48
Debt / Equity	3.24
Debt / EBITDA	n/a
Debt / FCF	-59.05
Interest Coverage	-0.77

Financial Efficiency

Return on equity (ROE) is -30.86% and return on invested capital (ROIC) is -2.45%.

Return on Equity (ROE)	-30.86%
Return on Assets (ROA)	-2.13%
Return on Capital (ROIC)	-2.45%
Revenue Per Employee	1.13B
Profits Per Employee	-206.40M
Employee Count	1,193
Asset Turnover	0.36
Inventory Turnover	2.65

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.40% in the last 52 weeks. The beta is 1.25, so PT Pyridam Farma Tbk's price volatility has been higher than the market average.

Beta (5Y)	1.25
52-Week Price Change	-16.40%
50-Day Moving Average	264.72
200-Day Moving Average	170.22
Relative Strength Index (RSI)	33.94
Average Volume (20 Days)	32,139,205

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PT Pyridam Farma Tbk had revenue of IDR 1.34 trillion and -246.24 billion in losses. Loss per share was -28.76.

Revenue	1.34T
Gross Profit	367.84B
Operating Income	-126.80B
Pretax Income	-250.68B
Net Income	-246.24B
EBITDA	-36.22B
EBIT	-126.80B
Loss Per Share	-28.76

Full Income Statement

Balance Sheet

The company has 505.42 billion in cash and 3.88 trillion in debt, giving a net cash position of -3,377.45 billion or -286.00 per share.

Cash & Cash Equivalents	505.42B
Total Debt	3.88T
Net Cash	-3,377.45B
Net Cash Per Share	-286.00
Equity (Book Value)	1.20T
Book Value Per Share	101.52
Working Capital	-607.04B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -34.57 billion and capital expenditures -31.19 billion, giving a free cash flow of -65.76 billion.

Operating Cash Flow	-34.57B
Capital Expenditures	-31.19B
Free Cash Flow	-65.76B
FCF Per Share	-5.57

Full Cash Flow Statement

Margins

Gross margin is 27.38%, with operating and profit margins of -9.44% and -18.33%.

Gross Margin	27.38%
Operating Margin	-9.44%
Pretax Margin	-18.66%
Profit Margin	-18.33%
EBITDA Margin	-2.70%
EBIT Margin	-9.44%
FCF Margin	n/a

Dividends & Yields

PT Pyridam Farma Tbk does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,500.00%
Shareholder Yield	-1,500.00%
Earnings Yield	-13.70%
FCF Yield	-2.65%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PT Pyridam Farma Tbk has an Altman Z-Score of 0.15. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.15
Piotroski F-Score	n/a